Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre de la Taille

Showing results (161-170 of 389) with videos related to

Pageof 39
Sort By:
World Journal of Urology|November 26, 2011
Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocolIdir Ouzaid, Evanguelos Xylinas, Alexandre Campeggi, et al.
International Journal of Cancer|December 2, 2011
Androgens regulate Hedgehog signalling and proliferation in androgen-dependent prostate cellsNanor Sirab, Stéphane Terry, Frank Giton, et al.
European Urology|August 2, 2011
The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillanceGuillaume Ploussard, Alexandre de la Taille, Younes Bayoud, et al.
BJU International|July 14, 2016
Impact of ischaemia time on renal function after partial nephrectomy: a systematic reviewXavier Rod, Benoit Peyronnet, Thomas Seisen, et al.
BJU International|April 2, 2014
External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancerMathieu Roumiguié, Jean-Baptiste Beauval, Thomas Filleron, et al.
Urology|March 18, 2003
Assessment of surgical technique and perioperative morbidity associated with extraperitoneal versus transperitoneal laparoscopic radical prostatectomyAndrs Hoznek, Patrick Antiphon, Tomasz Borkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cellsAlexandre de la Taille, Mark A Rubin, Min-Wei Chen, et al.
Urologic Oncology|July 2, 2011
Evaluation of combined oncologic and functional outcomes after robotic-assisted laparoscopic extraperitoneal radical prostatectomy: trifecta rate of achieving continence, potency and cancer controlEvanguelos Xylinas, Xavier Durand, Guillaume Ploussard, et al.
World Journal of Urology|July 3, 2014
Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy coresThomas Seisen, Françoise Roudot-Thoraval, Pierre Olivier Bosset, et al.
BJU International|November 6, 2010
Low pretreatment total testosterone (< 3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancerEvanguelos Xylinas, Guillaume Ploussard, Xavier Durand, et al.
Pageof 39

Showing results (161-170 of 389) with videos related to

Sort By:
Pageof 39
World Journal of Urology|November 26, 2011
Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocolIdir Ouzaid, Evanguelos Xylinas, Alexandre Campeggi, et al.
International Journal of Cancer|December 2, 2011
Androgens regulate Hedgehog signalling and proliferation in androgen-dependent prostate cellsNanor Sirab, Stéphane Terry, Frank Giton, et al.
European Urology|August 2, 2011
The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillanceGuillaume Ploussard, Alexandre de la Taille, Younes Bayoud, et al.
BJU International|July 14, 2016
Impact of ischaemia time on renal function after partial nephrectomy: a systematic reviewXavier Rod, Benoit Peyronnet, Thomas Seisen, et al.
BJU International|April 2, 2014
External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancerMathieu Roumiguié, Jean-Baptiste Beauval, Thomas Filleron, et al.
Urology|March 18, 2003
Assessment of surgical technique and perioperative morbidity associated with extraperitoneal versus transperitoneal laparoscopic radical prostatectomyAndrs Hoznek, Patrick Antiphon, Tomasz Borkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cellsAlexandre de la Taille, Mark A Rubin, Min-Wei Chen, et al.
Urologic Oncology|July 2, 2011
Evaluation of combined oncologic and functional outcomes after robotic-assisted laparoscopic extraperitoneal radical prostatectomy: trifecta rate of achieving continence, potency and cancer controlEvanguelos Xylinas, Xavier Durand, Guillaume Ploussard, et al.
World Journal of Urology|July 3, 2014
Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy coresThomas Seisen, Françoise Roudot-Thoraval, Pierre Olivier Bosset, et al.
BJU International|November 6, 2010
Low pretreatment total testosterone (< 3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancerEvanguelos Xylinas, Guillaume Ploussard, Xavier Durand, et al.
Pageof 39